Clinical Study
Estimation of Cachexia among Cancer Patients Based on Four Definitions
Table 2
Proportion of cancer patients with cachexia by cancer type.
| Cancer type | Cancer patients with cachexia ICD-9 code only | Cancer patients with any cachexia ICD-9 code | Cancer patients taking prescription medication indicative of cachexia | Cancer patients with 5% weight loss | Cancer patients with any one of the cachexia definitions |
| Breast, | 0.8% | 3.1% | 5.3% | 18.6% | 24.8% | Colorectal, | 2.5% | 6.1% | 6.2% | 16.4% | 25.5% | Esophagus, | 12.8% | 20.5% | 13.7% | 16.2% | 41.9% | Gastric, | 8.4% | 15.5% | 19.0% | 19.7% | 41.5% | Head/neck, | 6.1% | 17.1% | 6.1% | 19.9% | 37.0% | Liver, | 3.3% | 6.5% | 3.9% | 17.0% | 24.2% | Lung, | 6.4% | 9.7% | 14.2% | 15.2% | 31.1% | Pancreas, | 3.6% | 7.2% | 19.5% | 12.7% | 34.8% | Prostate, | 0.8% | 3.2% | 2.6% | 11.0% | 15.1% |
|
|